Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 31 (12) , 107816
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01-HL140961)
- National Institutes of Health (R01-HL146137)
- National Institutes of Health (R01-CA173852)
- National Institutes of Health (R01-CA134777)
- Riley Children's Foundation (T32HL007910)
This publication has 26 references indexed in Scilit:
- BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosisCell Research, 2019
- Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in miceEBioMedicine, 2019
- BH3-Mimetic Drugs: Blazing the Trail for New Cancer MedicinesCancer Cell, 2018
- A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous LeukemiaCancer Discovery, 2018
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaNature Medicine, 2018
- BH3-only protein BIM: An emerging target in chemotherapyEuropean Journal of Cell Biology, 2017
- Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD–induced myeloproliferationJournal of Experimental Medicine, 2017
- Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid LeukemiaCancer Cell, 2015
- FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent ProgenitorsCell Reports, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011